scholarly journals Canine parvovirosis: Still an existing problem.

2019 ◽  
Vol 75 (04) ◽  
pp. 6191-2019
Author(s):  
ALICJA WÓJCIK ◽  
STANISŁAW WINIARCZYK ◽  
JERZY ZIĘTEK
Keyword(s):  
Current Knowledge ◽  
Clinical Signs ◽  
Clinical Problem ◽  
Final Diagnosis ◽  
Diagnostic Methods ◽  
High Morbidity ◽  
Viral Pathogens ◽  
Treatment Protocols ◽  
Prophylactic Vaccination ◽  
Hemorrhagic Enteritis

Parvoviral infections of dogs are still a clinical problem throughout the world. This is despite the development of prevention, increased awareness among the owners and increasingly effective treatment protocols due to the extremely high virulence of the virus. Parvovirosis is a disease caused by a virus of the Parvoviridae family in various variants: CPV-2, CPV-2a, CPV-2b and CPV-2c, all of which produce similar clinical signs, including acute hemorrhagic enteritis and myocarditis. It is one of the most important viral pathogens, with extremely high morbidity and mortality. This study is a compendium of current knowledge about parvoviral infections in dogs. It describes their aetiology, pathogenesis and factors predisposing to parvovirosis. Special emphasis is placed on the description of clinical signs and treatment of sick dogs. Various diagnostic methods that are necessary to make the final diagnosis of the disease are described. The recommendations of the WSAVA on prophylactic vaccination are also analyzed.

scholarly journals Tick-Borne Encephalitis Virus (TBEV) Infection in Two Horses

Viruses ◽  
2021 ◽  
Vol 13 (9) ◽  
pp. 1775
Author(s):  
Theresa Maria Conze ◽  
Zoltán Bagó ◽  
Sandra Revilla-Fernández ◽  
Jürgen Schlegel ◽  
Lutz S. Goehring ◽  
...  
Keyword(s):  
Clinical Signs ◽  
Epidemiological Data ◽  
Final Diagnosis ◽  
Emerging Diseases ◽  
Encephalitis Virus ◽  
Diagnostic Methods ◽  
Molecular Diagnostic ◽  
Hybridization Technique ◽  
Tick Borne Encephalitis ◽  
Tick Borne Encephalitis Virus

A final diagnosis in a horse with clinical signs of encephalopathy can be challenging despite the use of extensive diagnostics. Clinical signs are often not pathognomonic and need to be interpreted in combination with (specific) laboratory results and epidemiological data of the geographical region of the origin of the case(s). Here we describe the diagnostic pathway of tick-borne encephalitis virus infection in two horses using established molecular diagnostic methods and a novel in situ hybridization technique to differentiate between regionally important/emerging diseases for central Europe: (i) hepatoencephalopathy, (ii) Borna disease virus, and (iii) West Nile virus infections.

scholarly journals CYPRINID HERPESVIRUS DISEASES

2019 ◽  
Vol 10 (1) ◽  
pp. 51-60
Author(s):  
Vladimir Radosavljević ◽  
Jelena Maksimović-Zorić ◽  
Ljubiša Veljović ◽  
Dragana Ljubojević ◽  
Miroslav Ćirković ◽  
...  
Keyword(s):  
Common Carp ◽  
Current Knowledge ◽  
Clinical Signs ◽  
Economic Losses ◽  
Viral Diseases ◽  
Viral Pathogens ◽  
Fish Family ◽  
Worldwide Distribution ◽  
Cyprinid Herpesvirus 3 ◽  
Herpesvirus 1

Cyprinidae, the largest known fish family including carp and minnows, has worldwide distribution with many species that are economically important in aquaculture. As would be expected, many viral pathogens can affect this group. The most pathogenic of these are the rhabdoviruses, a reovirus and three herpesviruses. Cyprinid herpesviruses can cause significant economic losses in aquaculture, and some of these viruses are oncogenic. The three herpesviruses are closely related but cause distinctly different diseases. Fish pox, caused by cyprinid herpesvirus 1 (CyHV-1), is one of the oldest known fish diseases, being recorded as early as 1563. It takes the form of a hyperplastic, epidermal papilloma on common carp. Cyprinid herpesvirus 2 (CyHV-2) is causative agent of herpesviral hematopoietic necrosis (HVHN). The herpesvirus was first isolated from cultured goldfish in Japan. It causes a severe epizootic but no external clinical signs were apparent on affected fish. One of the most economically important and researched viral diseases of carp is koi herpesviral disease caused by cyprinid herpesvirus 3 (CyHV-3). The aim of this paper is to present the current knowledge on herpesvirus diseases of the cyprinids.

scholarly journals Genitourethral infections caused by D–K serotypes ofChlamydia trachomatis

2015 ◽  
Vol 156 (1) ◽  
pp. 19-23
Author(s):  
Péter Holló ◽  
Hajnalka Jókai ◽  
Krisztina Herszényi ◽  
Sarolta Kárpáti
Keyword(s):  
Chlamydia Trachomatis ◽  
Current Knowledge ◽  
Treatment Options ◽  
Clinical Signs ◽  
Diagnostic Techniques ◽  
Treatment Protocols ◽  
Sexually Transmitted ◽  
Screening Programs ◽  
Leading Role ◽  
Special Circumstances

Sexually transmitted infections of the urogenital tract are most commonly caused by the intracellular bacteria Chlamydia trachomatis worldwide, resulting the clinical picture of acute urethritis in men as well as urethritis and endocervicitis in women. As women often present with few symptoms only or a completely symptom-free disease course, one of the most important long-term complications is chronic pelvic inflammatory disease often followed by the development of infertility caused by chronic scar formation. Well-organized screening programs are considered to have a leading role in the prevention of disease spreading and long lasting unwanted complications. Antibiotic treatment options are often influenced by special circumstances, such as pregnancy and several complicated clinical forms. The aims of the authors are to give a concise review on the current knowledge regarding Chlamydia trachomatis infections and summarize typical clinical signs, modern diagnostic techniques as well as accepted treatment protocols and basic aspects of screening. Orv. Hetil., 2015, 156(1), 19–23.

Assessment of Nanomodified Endotracheal Tubes in a Bench Top Airway Model

2009 ◽  
Vol 1209 ◽  
Author(s):  
Mary C. Machado ◽  
Daniel Chang ◽  
Thomas J Webster ◽  
Keiko M Tarquinio
Keyword(s):  
Mechanical Ventilation ◽  
Bacterial Growth ◽  
Bacterial Adhesion ◽  
Bacterial Resistance ◽  
Flow System ◽  
Clinical Signs ◽  
Diagnostic Methods ◽  
High Morbidity ◽  
Endotracheal Tubes ◽  
Airway Model

AbstractVentilator associated pneumonia (VAP) is a serious and costly clinical problem. Specifically, receiving mechanical ventilation over 24 hours increases the risk of VAP and is associated with high morbidity, mortality and medical costs. This complication is especially hard to diagnose in children because of non-specific clinical signs and lack of established diagnostic methods. Cost effective endotracheal tubes (ETTs) that are resistant to bacterial infection would be essential tools for the prevention of VAP. In addition to their bacterial resistance, ETT with magnetic nanoparticles could aid in the diagnosis of VAP allowing physicians to locate infections with greater accuracy. The objective of this study was twofold, first to develop strategies to decrease bacterial adhesion on nano-rough ETT and secondly to develop better methods to assessin vitrobacterial adhesion or biofilm formation on ETT. In preliminary tests, nanomodified polyvinyl chloride (PVC) ETTs has been shown to be effective at reducing bacterial colonization. This study also sought to evaluate the bacterial resistance of these ETTs more effectively by creating a bench top airway model, which can create a similar environment to the flow system that ETTs are exposed toin vivo. The airway model designed to test ETTs has two Plexiglas chambers representing the oropharynx and the lungs, a tube representing the trachea and finally an intricate pumping system to the oropharynx with bacteria flow and to the lung with simulated compliance and resistance. ETTs were connected to a ventilator and passing the oropharynx into the trachea and observed under the mechanical ventilation and continuous bacterial flow system. In addition, the study examined dual gas flow conditions and their effect on bacterial growth of ETT. In no less than three separate trials in the airway chamber, each ETT will be tested for its effectiveness at the reduction of bacterial growth within the airway by sampling from both lung and oropharynx chambers during continuous operation. Special attention will be given to the long-term effects on the ETT by including a study that lasts longer than ten days. Both the bacterial proliferation in the two chambers and on the ETT itself will be carefully analyzed. This specialized testing should yield valuable information on the efficacy of nanomodified ETT in airway conditions and will provide further evidence to determine if nanomodified ETTs are a valid solution to VAP.

Retrospective Diagnosis of Pontocerebellar Hypoplasia Type 1B in a Family with Two Deceased Newborn Children

2020 ◽  
Author(s):  
Irena Bradinova ◽  
Silvia Andonova ◽  
Alexey Savov
Keyword(s):  
Clinical Signs ◽  
Final Diagnosis ◽  
Population Based ◽  
Neuromuscular Disorder ◽  
Population Characteristics ◽  
High Risk Population ◽  
Pontocerebellar Hypoplasia ◽  
Clinical Genetic ◽  
Retrospective Diagnosis ◽  
Newborn Children

AbstractPontocerebellar hypoplasia type 1B is a severe autosomal recessive neurologic disorder characterized by a combination of cerebellar and spinal motor neuron degeneration beginning at birth. Pontocerebellar hypoplasia type 1B is caused by mutations in EXOSC3 gene. High prevalence of the p.Gly31Ala mutation was found recently, especially in the Roma ethnic minority. We present a young Bulgarian Roma family with two deceased newborn children manifesting severe neuromuscular disorder including severe muscle weakness, respiratory distress, and multiple joint contractures. Based on the clinical signs and family's population characteristics, DNA testing for the previously described EXOSC3 in Bulgarian Roma mutation c.92G > C; p.Gly31Ala was performed on blood samples of both parents and they were found to be heterozygous carriers. This finding indirectly confirmed the diagnosis of pontocerebellar hypoplasia type B in the deceased offspring. Knowledge of population-specific molecular bases of genetic conditions was the key to final diagnosis in the presented family. Designing of population-based clinical-genetic panels may be a powerful diagnostic tool for patients with such origin. Preconception carrier screening in high-risk population groups is a feasible option to discuss.

Malignant Pleural Effusion: Still a Long Way to Go

2019 ◽  
Vol 14 (1) ◽  
pp. 24-30 ◽  
Author(s):  
Fausto Meriggi
Keyword(s):  
Pleural Effusion ◽  
Malignant Pleural Effusion ◽  
English Language ◽  
Metastatic Cancer ◽  
Primary Tumour ◽  
Clinical Problem ◽  
Therapeutic Options ◽  
High Morbidity ◽  
Sclerosing Agents ◽  
Pubmed Database

Background:Malignant pleural effusion, which is a common clinical problem in patients with cancer, may be due to both primary thoracic tumours or to a metastatic spread in the chest and constitutes the first sign of disease in approximately 10% of patients. Almost all cancers can potentially produce a pleural effusion. The presence of malignant tumour cells in the pleural fluid is generally indicative of advanced disease and is associated with high morbidity and mortality with reduced therapeutic options. Dyspnoea during mild physical activity or at rest is generally the typical sign of restrictive respiratory failure. </P><P> Methods: This is a systematic review of all the main articles in the English language on the topic of malignant pleural effusion and reported by the Pubmed database from 1959 to 2018. I reviewed the literature and guidelines with the aims to focus on what is known and on future pathways to follow the diagnosis and treatment of malignant pleural effusions.Results:The main goal of palliation of a malignant pleural effusion is a quick improvement in dyspnoea, while thoracentesis under ultrasound guidance is the treatment of choice for patients with a limited life expectancy or who are not candidates for more invasive procedures such as drainage using an indwelling small pleural catheter, chemical pleurodesis with sclerosing agents, pleurectomy or pleuro-peritoneal shunt.Conclusion:Despite progress in therapeutic options, the prognosis remains severe, and the average survival is 4-9 months from the diagnosis of malignant pleural effusion. Moreover, mortality is higher for patients with malignant pleural effusion compared with those with metastatic cancer but no malignant pleural effusion. Therefore, the prognosis of these patients primarily depends on the underlying disease and the extension of a primary tumour. This review focuses on the most relevant updates in the management of malignant pleural effusion.

scholarly journals L2HGDH Missense Variant in a Cat with L-2-Hydroxyglutaric Aciduria

Genes ◽  
2021 ◽  
Vol 12 (5) ◽  
pp. 682
Author(s):  
Matthias Christen ◽  
Nils Janzen ◽  
Anne Fraser ◽  
Adrian C. Sewell ◽  
Vidhya Jagannathan ◽  
...  
Keyword(s):  
Current Knowledge ◽  
Genetic Defect ◽  
Clinical Signs ◽  
Missense Variant ◽  
Microcytic Anemia ◽  
Abnormal Behavior ◽  
Functional Candidate Gene ◽  
History Of ◽  
The Brain ◽  
Hydroxyglutaric Acid

A 7-month-old, spayed female, domestic longhair cat with L-2-hydroxyglutaric aciduria (L-2-HGA) was investigated. The aim of this study was to investigate the clinical signs, metabolic changes and underlying genetic defect. The owner of the cat reported a 4-month history of multiple paroxysmal seizure-like episodes, characterized by running around the house, often in circles, with abnormal behavior, bumping into obstacles, salivating and often urinating. The episodes were followed by a period of disorientation and inappetence. Neurological examination revealed an absent bilateral menace response. Routine blood work revealed mild microcytic anemia but biochemistry, ammonia, lactate and pre- and post-prandial bile acids were unremarkable. MRI of the brain identified multifocal, bilaterally symmetrical and T2-weighted hyperintensities within the prosencephalon, mesencephalon and metencephalon, primarily affecting the grey matter. Urinary organic acids identified highly increased levels of L-2-hydroxyglutaric acid. The cat was treated with the anticonvulsants levetiracetam and phenobarbitone and has been seizure-free for 16 months. We sequenced the genome of the affected cat and compared the data to 48 control genomes. L2HGDH, coding for L-2-hydroxyglutarate dehydrogenase, was investigated as the top functional candidate gene. This search revealed a single private protein-changing variant in the affected cat. The identified homozygous variant, XM_023255678.1:c.1301A>G, is predicted to result in an amino acid change in the L2HGDH protein, XP_023111446.1:p.His434Arg. The available clinical and biochemical data together with current knowledge about L2HGDH variants and their functional impact in humans and dogs allow us to classify the p.His434Arg variant as a causative variant for the observed neurological signs in this cat.

scholarly journals Brain Abscess Caused by Nocardia: Case Report and Literature Review

2020 ◽  
Author(s):  
Guilherme Finger ◽  
Maria Eduarda Conte Gripa ◽  
Tiago Paczko Bozko Cecchini ◽  
Tobias Ludwig do Nascimento
Keyword(s):  
Case Report ◽  
Antibiotic Therapy ◽  
Brain Abscess ◽  
Clinical Signs ◽  
Occipital Lobe ◽  
High Morbidity ◽  
Rare Clinical Entity ◽  
Brain Abscesses

AbstractNocardia brain abscess is a rare clinical entity, accounting for 2% of all brain abscesses, associated with high morbidity and a mortality rate 3 times higher than brain abscesses caused by other bacteria. Proper investigation and treatment, characterized by a long-term antibiotic therapy, play an important role on the outcome of the patient. The authors describe a case of a patient without neurological comorbidities who developed clinical signs of right occipital lobe impairment and seizures, whose investigation demonstrated brain abscess caused by Nocardia spp. The patient was treated surgically followed by antibiotic therapy with a great outcome after 1 year of follow-up.

scholarly journals Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management

2021 ◽  
Vol 10 (15) ◽  
pp. 3239
Author(s):  
Miguel A. Ortega ◽  
Oscar Fraile-Martínez ◽  
Cielo García-Montero ◽  
Miguel A. Álvarez-Mon ◽  
Chen Chaowen ◽  
...  
Keyword(s):  
Inflammatory Responses ◽  
Current Knowledge ◽  
Varicose Veins ◽  
Clinical Signs ◽  
Clinical Manifestations ◽  
Significant Loss ◽  
Venous Hypertension ◽  
Chronic Venous Disease ◽  
Venous Disease ◽  
Environmental Agents

Chronic venous disease (CVD) is a multifactorial condition affecting an important percentage of the global population. It ranges from mild clinical signs, such as telangiectasias or reticular veins, to severe manifestations, such as venous ulcerations. However, varicose veins (VVs) are the most common manifestation of CVD. The explicit mechanisms of the disease are not well-understood. It seems that genetics and a plethora of environmental agents play an important role in the development and progression of CVD. The exposure to these factors leads to altered hemodynamics of the venous system, described as ambulatory venous hypertension, therefore promoting microcirculatory changes, inflammatory responses, hypoxia, venous wall remodeling, and epigenetic variations, even with important systemic implications. Thus, a proper clinical management of patients with CVD is essential to prevent potential harms of the disease, which also entails a significant loss of the quality of life in these individuals. Hence, the aim of the present review is to collect the current knowledge of CVD, including its epidemiology, etiology, and risk factors, but emphasizing the pathophysiology and medical care of these patients, including clinical manifestations, diagnosis, and treatments. Furthermore, future directions will also be covered in this work in order to provide potential fields to explore in the context of CVD.

scholarly journals Nanotechnology as an Anti-Infection Strategy in Periprosthetic Joint Infections (PJI)

2021 ◽  
Vol 6 (2) ◽  
pp. 91
Author(s):  
Pier Francesco Indelli ◽  
Stefano Ghirardelli ◽  
Ferdinando Iannotti ◽  
Alessia Maria Indelli ◽  
Gennaro Pipino
Keyword(s):  
Joint Infection ◽  
Treatment Strategies ◽  
High Morbidity ◽  
Treatment Protocols ◽  
Joint Infections ◽  
Prevention And Treatment ◽  
Efficient Control ◽  
Cement Joint ◽  
Clay Nanotubes

Background: Periprosthetic joint infection (PJI) represents a devastating consequence of total joint arthroplasty (TJA) because of its high morbidity and its high impact on patient quality of life. The lack of standardized preventive and treatment strategies is a major challenge for arthroplasty surgeons. The purpose of this article was to explore the potential and future uses of nanotechnology as a tool for the prevention and treatment of PJI. Methods: Multiple review articles from the PubMed, Scopus and Google Scholar databases were reviewed in order to establish the current efficacy of nanotechnology in PJI preventive or therapeutic scenarios. Results: As a prevention tool, anti-biofilm implants equipped with nanoparticles (silver, silk fibroin, poly nanofibers, nanophase selenium) have shown promising antibacterial functionality. As a therapeutic tool, drug-loaded nanomolecules have been created and a wide variety of carrier materials (chitosan, titanium, calcium phosphate) have shown precise drug targeting and efficient control of drug release. Other nanotechnology-based antibiotic carriers (lipid nanoparticles, silica, clay nanotubes), when added to common bone cements, enhanced prolonged drug delivery, making this technology promising for the creation of antibiotic-added cement joint spacers. Conclusion: Although still in its infancy, nanotechnology has the potential to revolutionize prevention and treatment protocols of PJI. Nevertheless, extensive basic science and clinical research will be needed to investigate the potential toxicities of nanoparticles.

Sign in / Sign up

Export Citation Format

Share Document